News
A common and unsightly skin cancer that can turn deadly has been undetectable for more than a year in a patient treated with ...
USA: A recent literature review published in Skin Appendage Disorders has raised concerns about a possible link between ...
Many head and neck cancer survivors felt that they lacked knowledge on topics including mental health, diet and exercise, smoking, and more.
3h
Zacks Investment Research on MSNMRK, Daiichi Begin Pivotal Esophageal Cancer Study With ADC DrugMerck MRK and Japan’s Daiichi Sankyo announced the dosing of the first patient in the phase III IDeate-Esophageal01 study evaluating their B7-H3 directed DXd antibody-drug conjugate (ADC), ifinatamab ...
RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.
8h
Clinical Trials Arena on MSNDaiichi Sankyo and MSD announce first subject dosing in oesophageal cancer trial"Daiichi Sankyo and MSD announce first subject dosing in oesophageal cancer trial" was originally created and published by ...
A former Top Chef alum shared encouraging news after being diagnosed with stage four tongue cancer a year ago. On May 7, the Top Chef: New Orleans and Top Chef: Charleston star Shirley Chung posted on ...
The College of American Pathologists recently updated its evidence-based guideline recommendations for the testing of human papillomavirus in head and neck carcinomas. Guideline co-chairs William ...
Five-year data from the KEYNOTE-048 trial support the use of pembrolizumab and pembrolizumab-chemotherapy as standards of care, researchers wrote.
Mike Masterson, a longtime Arkansas journalist, died Sunday at the age of 78, according to his wife, Jeanetta McCroskey. He ...
Incyte Corp.’s Zynyz (retifanlimab-dlwr) has received another U.S. FDA approval and put some distance between it and a 2021 ...
FDA-approved as the first and only approved first line treatment for advanced squamous cell carcinoma of the anal canal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results